Reference ID: 3115694
11 DESCRIPTION • with the lowest effective dose. (2) oxidase inhibitors (4) breakfast for appetite control. The dosage may be adjusted to the patient’s need.
Download Reference ID: 3115694
Information
Domain:
Source:
Link to this page:
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
South Carolina Drug Statutes - LCLE
lcle.la.govSouth Carolina Drug Statutes South Carolina Code of Laws: Title 44 Health Code 1 SCHEDULE CRITERIA AND COMPOSITION OFFENSES/PENALTIES ENHANCEMENTS/BENEFIT
Approval Status of New Drug during 1971-1981
www.cdsco.nic.inApproval Status of New Drug during 1971-1981 S. No Drug Indication Date of Approval 1. Hydroxyurea USP Tablet 200 mg Anti-neoplastic agent Jan,1971
NEW ZEALAND DATA SHEET DUROMINE - Medsafe
www.medsafe.govt.nznew zealand data sheet duromine ® duromine® page 1 of 8 1 product name duromine 15 mg capsules duromine 30 mg capsules 2 qualitative and quantitative composition
The impact of pulmonary arterial hypertension (PAH) on the ...
www.phaeurope.orgTHE IMPACT OF PULMONARY ARTERIAL HYPERTENSION (PAH) ON THE LIES OF PATIENTS AND CARERS: RESLTS FRM AN INTERNATINAL SRVEY 4 5 Illustration1. PAH: histopathological features www.PAH-info.com
QT PROLONGATION and TORSADES DE POINTES: DRUGS …
www.rxfiles.caThe Rx Files: Q&A Summary Mar, 2005 S. Downey BSP, B. Jensen BSP, L.Regier BSP, BA PROMOTING OPTIMAL DRUG THERAPY www.RxFiles.ca QT PROLONGATION and TORSADES DE POINTES: DRUGS and SUDDEN DEATH